The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it has been certified as a 2025 Great Place To Work® ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

“This campaign is intentionally emotional and family-centric, drawing on the importance of staying healthy for your loved ones so you can protect what you’ve worked so hard to create and can continue ...

Abbott LaboratoriesABT confirmed Thursday plans to buy Madison, Wis.-based Exact SciencesEXAS in a deal valuing the cancer-finding specialist at up to $23 billion. Exact shares surged 16.8%, closing ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

Exact Sciences Corp (NASDAQ:EXAS) shares are trading lower in Wednesday’s after-hours session on the heels of the company’s first-quarter results. Here’s a rundown of the report. Screening revenue was ...

In the latest quarter, 7 analysts provided ratings for Exact Sciences (NASDAQ:EXAS), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the ...

The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Evercore ISI Group on January 5, 2026. The analyst firm set a price target for $105.00 expecting EXAS to rise to within 12 ...